Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 061624/0775 | |
| Pages: | 29 |
| | Recorded: | 10/07/2022 | | |
| Attorney Dkt #: | 24797-US-PCT |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE MERCK SHOULD BE MERCK SHARP & DOHME CORP. PREVIOUSLY RECORDED AT REEL: 061297 FRAME: 0883. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17801409
|
Filing Dt:
|
08/22/2022
|
|
Publication #:
|
|
Pub Dt:
|
04/20/2023
| | | | |
|
Title:
|
METHODS FOR TREATING CANCER USING A COMBINATION OF A PD-1 ANTAGONIST, A CTLA4 ANTAGONIST, AND LENVATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
|
|
|
Assignee
|
|
|
|
|
| 126 EAST LINCOLN AVENUE |
| RAHWAY, NEW JERSEY 07065 |
|
|
Correspondence name and address
|
| |
MERCK
|
| |
126 EAST LINCOLN AVENUE
|
| |
RAHWAY, NJ 07065
|
Search Results as of:
05/27/2024 10:43 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
